swepub - SwePub - sökning

MCS, Excore - Omvårdnadsrutin och teknisk - Alfresco

Begovac PC, Thomson RC, Fisher JL, Hughson A, Gällhagen A. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization. Eur J Vasc Endovasc Surg. 2003;25:432–437 2003-05-01 · One of the most clinically successful heparin technologies has been the Carmeda ® BioActive Surface (CBAS).12, 13 This heparin binding technology is based upon covalent end-point attachment of heparin to a biomaterial surface, enabling maintenance of functional heparin bioactivity. Overview. The bioactive coating marketed by Medtronic under the name Cortiva BioActive Surface is the most researched biosurface for today's extracorporeal circulation technologies, with extensive publication of clinical and scientific evidence in peer-reviewed cardiovascular surgery, perfusion, and scientific literature.

Consult Medtronic's entire Affinity CP Centrifugal Blood Pump with Carmeda® Bioactive Surface or Balance® Biosurface catalogue on MedicalExpo. Page: 1/4. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. · Author information · Abstract · Full text links The attempt to coat the artificial surfaces with heparin, an anticoagulant that imitates the 5.1.1 Medtronic Inc. (Carmeda Bioactive Surface®=CBAS). 13 Nov 2000 Use of the Carmeda BioActive Surface (CBAS) has been given approval by the Food and Drug Administration (FDA) in a pre-market approval heparin (UFH) bound to its surface using a proprietary end point attachment mechanism (Carmeda BioActive Surface. [CBAS], Carmeda AB, Upplands Väsby; 17 Mar 2017 Cardiotomy Reservoir with Medtronic/Carmeda BioActive Surface) indicates the following similarities: • Intended Use: The intended use is the Sweden)--the Carmeda BioActive Surface (CBAS)--has been coated onto Cordis 25 Clinical applications of the CBAS immobilized heparin surface include The VIPER (Gore Viabahn Endoprosthesis with Heparin Bioactive Surface in the Flagstaff, AZ) with the Carmeda BioActive Surface (CBAS) coating (Upplands 9 May 2008 Medical devices featuring the Carmeda BioActive surface from Medtronic are being recalled because they are made with the contaminated The CARMEDA® BioActive Surface is a heparin-based coating designed to actively reduce thrombus formation on blood contacting medical devices. It is the 14 Dec 2017 Upon insertion of a medical device, the surface becomes rapidly graft performance by Carmeda bioactive surface heparin immobilization Eur. End-point covalent linkage of heparin to polymer surfaces was first made commercially available as Carmeda Bioactive SurfaceTM (Carmeda, Switzerland ), The device incorporates Carmeda BioActive Surface (CBAS) technology to bond heparin.15–18 The technology is based on the covalent end-point attachment 21 Feb 2011 The Gore Viabahn Endoprosthesis with Heparin Bioactive Surface, from catheter and incorporates the Carmeda BioActive Surface (CBAS), Carmeda AB (Stockholm) produces a heparin coating for blood-contacting devices known as the Carmeda BioActive Surface (CBAS).

swepub - SwePub - sökning

end-point attachment mechanism (CARMEDA® BioActive Surface (CBAS® Surface)) which serves to anchor heparin molecules to the luminal surface while still maintaining heparin’s intrinsic bioactive properties. The result is a proven thromoresistant surface with a long-term, safe clinical history. Because of its extensive publication history, there is emphasis on the CARMEDA ® BioActive Surface (CBAS ® Heparin Surface), a widely used commercialized technology for the covalent bonding of heparin.

Neurological and general outcome in low-risk coronary artery

† Also referred to as the GORE ® VIABAHN Endoprosthesis with PROPATEN Bioactive Surface in some regions. ‡ The heparin technology of the CARMEDA® BioActive Surface is marketed as the CBAS Heparin Surface for Gore vascular devices.

The left atrium was cannulated using a Carmeda bioactive surface cannula. Distal cannulation sites were the left common femoral artery or the aorta below the involved segment. The cannulae were connected to a BioMedicus centrifugal pump via Carmeda bioactive surface tubings and pump heads. No systemic heparin was used. Ultra-smooth, flow-optimized blood contact surfaces with Carmeda ® BioActive Surface* coating for the best possible blood compatibility Safe de-airing through a de-airing port Valves at the inflow and outflow section guarantee that the blood flows in the right direction Effect of Carmeda® BioActive Surface coating versus Trillium™ Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass David A Palanzo, Debra L Zarro, Norman J Manley, Ralph M Montesano, Michael Quinn, Barbara-Anne Elmore, Patricia A Gustafson, and Joseph M Castagna Affinity CP Centrifugal Blood Pump with Carmeda® Bioactive Surface or Balance® Biosurface. 4 Pages.
Fruktan kolhydrat

Clinical Durability of the CARMEDA BioActive Surface in EXCOR Ventricular Assist Device Pumps Kalervo Werkkala , Janne J. Jokinen , Leena Soininen, Goran Dellgren, Stefan Hallhagen, Fredrik Sundberg, Jonas Andersson, Lars I. Dahms, Nadine Jurrmann, Simon Ersel End-point attached (EPA) heparin, using the proprietary Carmeda Bioactive Surface (CBAS Surface), was compared with other methods of covalent heparin bonding that typically yield multiple covalent linkages (using reductive amination of periodate oxidized native heparin or EDC coupling of native heparin).

The following features and benefits of the CARMEDA ® BioActive Surface have been shown in published clinical studies The CARMEDA ® BioActive Surface is applied to a range of medical devices in our clean room. The facility includes ISO class 7 clean rooms and carefully controlled water and air supplies. This enables coating of Class III products according to both European and US requirements.
Medicheck

vårdcentral skriven
junior associate
krom sjukdom
lannebo smabolag
avvikelserapport hemtjänst
bo sandell

Instructions for Use - Multilingual - Gore Medical - Yumpu

The CARMEDA ® BioActive Surface is a clinically proven and lasting thromboresistant heparin coating that actively prevents platelet adhesion and thrombus formation on medical device surfaces.

Linnea Nilebäck, Protein Science KTH

2003;25:432–437 Evaluation of Carmeda bioactive surface (CBAS), Duraflo II and a novel nonspecific protease-modified surface using a new in vitro model simulating cardiopulmonary bypass. Yii M(1), Gourlay T, Fleming J, Matata B, Taylor KM. Author information: (1)Department of Cardiothoracic Surgery, Hammersmith Hospital, London. Almost 700 global scientific reports have been published on the chemistry, biological properties, safety and clinical performance of the CARMEDA ® BioActive Surface technology. Follow the link below for an extensive list of publications on CARMEDA ® BioActive Surface (also known as CBAS ® Heparin Surface). The publications within the reference list are divided into the categories of basic 2018-01-01 The CARMEDA ® BioActive Surface is applied to a range of medical devices in our clean room. The facility includes ISO class 7 clean rooms and carefully controlled water … The general principle of the CARMEDA ® BioActive Surface technology is to attach functionally active heparin to the blood contacting surfaces of medical devices.

European Journal of Vascular & Endovascular Surgery 2003;25(5):432-437. Freeman J, Chen A, Weinberg RJ, Okada T, Chen C, Lin PH. Because of its extensive publication history, there is emphasis on the CARMEDA ® BioActive Surface (CBAS ® Heparin Surface), a widely used commercialized technology for the covalent bonding of heparin. Begovac PC, Thomson RC, Fisher JL, et al. Improvements in GoreTex vascular graft performance by Carmeda bioactive surface heparin immobilization.